clofibric acid has been researched along with probucol in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kłosiewicz-Latoszek, L; Szostak, WB | 1 |
| Clerc, C; Cloarec, L; Doualin, G; Fertil, V; Legras, B; Ruelland, A | 1 |
| Beaumont, JL; Beaumont, V; Buxtorf, JC; Carcone, B; Doucet, F; Edouard, L; Jacotot, B | 1 |
| Hanioka, N; Kawashima, Y; Kozuka, H; Matsumura, M | 1 |
| Santafé Oroz, J; Segarra Domènech, J | 1 |
| Mordasini, R; Oster, P; Riesen, W; Riva, G | 1 |
| Davignon, J; Dubreuil-Quidoz, S; LeLorier, J; Lussier-Cacan, S | 1 |
| Farmer, JA; Gotto, AM | 1 |
| Murphy, MJ; O'Reilly, DS; Packard, CJ | 1 |
| Fukumoto, Y; Shimokawa, H | 1 |
3 review(s) available for clofibric acid and probucol
| Article | Year |
|---|---|
[Pharmacologic therapy of atherosclerosis (I). Current possibilities].
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Clofibrate; Clofibric Acid; Fenofibrate; Gemfibrozil; Glycosaminoglycans; Humans; Ion Exchange Resins; Lipoproteins; Nicotinic Acids; Pentanoic Acids; Probucol | 1983 |
Antihyperlipidaemic agents. Drug interactions of clinical significance.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibric Acid; Colestipol; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol | 1994 |
[Adverse effects of lipid-lowering medications].
Topics: Anticholesteremic Agents; Arteriosclerosis; Clofibric Acid; Contraindications; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Ion Exchange Resins; Life Style; Probucol | 2007 |
2 trial(s) available for clofibric acid and probucol
| Article | Year |
|---|---|
Effects of several lipid-lowering drugs on skin total and esterified cholesterol.
Topics: Cholesterol Esters; Clinical Trials as Topic; Clofibric Acid; Fenofibrate; Fibric Acids; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Probucol; Random Allocation; Skin | 1986 |
[Behavior of high-density lipoproteins in drug lipid-lowering treatment].
Topics: Adult; Apoproteins; Bezafibrate; Cholesterol; Cholesterol, HDL; Clofibric Acid; Colestipol; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Lipoproteins, HDL; Male; Middle Aged; Probucol | 1982 |
5 other study(ies) available for clofibric acid and probucol
| Article | Year |
|---|---|
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol | 1991 |
Transitory deficit in high-density lipoproteins and apolipoprotein A-I.
Topics: Apolipoprotein A-I; Apolipoproteins A; Bezafibrate; Clofibric Acid; Drug Therapy, Combination; Fibric Acids; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Male; Middle Aged; Probucol | 1990 |
Induction of microsomal stearoyl-CoA desaturation by the administration of various peroxisome proliferators.
Topics: Adipates; Animals; Aspirin; Clofibric Acid; Dibutyl Phthalate; Diethylhexyl Phthalate; Enzyme Induction; Fatty Acid Desaturases; Lipids; Male; Microbodies; Microsomes, Liver; Organoids; Probucol; Rats; Rats, Inbred Strains; Stearoyl-CoA Desaturase | 1983 |
Experience with probucol in the treatment of hypercholesterolemia.
Topics: Cholesterol; Clofibrate; Clofibric Acid; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Patient Compliance; Phenols; Probucol | 1982 |
Fibrates and HDL cholesterol.
Topics: Apolipoprotein A-I; Cholesterol, HDL; Clofibric Acid; Dose-Response Relationship, Drug; Female; Fenofibrate; Fibric Acids; Humans; Hypolipidemic Agents; Hypolipoproteinemias; Middle Aged; Probucol | 1997 |